Preliminary Program
4th Raisa Gorbacheva Memorial Meeting on Hematopoietic Stem Cell Transplantation, Saint Petersburg, Russia, September 18–20, 2010
September 18
September 19
Session 1. Hematopoietic Stem Cell Transplantation: GvHD-GvL
Session 2. Hematopoietic Stem Cell Transplantation: GvHD-GvL, Extracorporeal photopheresis
Session 3. Hematopoietic Stem Cell Transplantation. Pediatric Session
September 20
Session 4. Hematopoietic Stem Cell Transplantation in Patients with Haematological Malignancies
Session 5. Hematopoietic Stem Cell Transplantation: Aplastic Anemia
Session 6. Hematopoietic Stem Cell Transplantation: Infection complications
September 18
Satellite Meetings
Venue: Conference hall of Baltic Star Hotel State Complex Palace of Congress (Konstantinovsky Palace), Strelna, Berezovaya Alley, 3, Saint Petersburg
Welcome reception
Konstantinovsky Palace, Strelna
September 19
8.00-8.30
Registration of participants
8.30-9.00
Opening speeches
Mikhail Didur
Boris Afanasyev
Thomas Buchner
Special Lectures
Chairmen: V. Savchenko, H.-J. Kolb, T. Buchner
9.00-9.30
Buchner Thomas. Raisa Gorbacheva Memorial Lecture. Strategies against relapse in AML
9.30-10.00
Kolb Hans-Jochem. Mechanisms of graft-versus-leukemia reactions in HLA-identical, HLA-haploidentical transplants and cord blood transplants
10.00-10.30
Ferrara James. Biomarkers of Acute GVHD
10.30-11.00
Fibbe Willem. Mesenchymal stromal cells: Safety issues for clinical application
11.00-11.30
Schmitz Norbert. G-CSF for the purposes of high-dose chemotherapy and hematopoietic stem cell transplantation
11.30-12.00
Burdach Stefan. Frontiers of cellular therapy in childhood cancer: overcoming tumor escape by selective alloreactive T cells
12.00-12.15
Zurabov Alexander. Investment in innovation activities in terms of cell technologies: view of venture investor
12.15-12.40
Coffee break and posters
Session 1. Hematopoietic Stem Cell Transplantation: GvHD-GvL
Chairmen: A. Zander, H. Greinix, W. Fibbe
12.40-13.00
Schmid Christoph. Innovative strategies to augment the Graft-versus-leukemia effect in allogeneic stem cell transplantation for AML
13.00-13.20
Ayuk Francis. Diagnosis and therapy of chronic GvHD
13.20-13.40
Holler Ernst. GvHD - actual pathophysiological and therapeutical aspects
13.40-13.55
Afanasyev Boris. Treatment of patients with post-transplant relapses
13.55-14.10
Savchenko Valeriy. Evidence-based aspects of mesenchymal stem cells using for GVHD prophylaxis and treatment
14.10-15.00
Lunch. Poster session
Session 2. Hematopoietic Stem Cell Transplantation: GvHD-GvL, Extracorporeal photopheresis
Chairmen: V. Koza, J. Ferrara, F. Auyk
15.00-15.20
Greinix Hildegard. Extracorporeal photopheresis for treatment of graft-versus-host disease
15.20-15.40
Heshmati Farhad. Extracorporeal photochemotherapy, indications, techniques and mechanisms of action
15.40-16.00
Del Fante Claudia. Extracorporeal photopheresis in the treatment of GvHD in children
Session 3. Hematopoietic Stem Cell Transplantation. Pediatric Session
Chairmen: O. Aleinikova, S. Kojima, S. Burdach
16.00-16.20
Muller Ingo. Clinical potential of mesenchymal stem cells in pediatric BMT
16.20-16.35
Aleinikova Olga. Bone marrow transplantation for children with acute myeloid leukemia: pro et contra
16.35-16.55
Wagemaker Gerard. Genetic correction of hematopoietic stem cells for advanced cell therapy of lysosomal enzyme deficiencies
16.55-17.10
Rumyantsev Alexander. Circulating nucleic acids in biological fluids and their role in detection of minimal residual disease in children with hematological malignancies
17.10-17.20
Semenova Elena. Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning regimen in children
17.20-17.30
Maschan Alexey. Kinetics of progenitor cell mobilization using G-CSF and plerixafor in children with hematological and nonhematological malignancies
17.30-17.40
Samochatova Elena. Current treatment of mature B-NHL/ALL in children and adolescent in regional pediatric clinics of Russian Federation
17.40-17.55
Mentkevich George. High dose chemotherapy with PBSC support in pediatric brain tumor patients
September 20
Session 4. Hematopoietic Stem Cell Transplantation in Patients with Haematological Malignancies
Chairmen: A. Sureda, T. Ruutu, Poddubnaya I.
9.00-9.20
Sureda Anna. Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma
9.20-9.40
Zander Axel. Hematopoietic stem cell transplantation in patients with myelofibrosis
9.40-10.00
Ruutu Tapani. A second allogeneic hematopoietic stem cell transplantation for relapse of malignant disease: Outcome and Predictive Factors
10.00-10.20
Wisloff Finn. The title will be detailed
10.20-10.40
Tangen Jon Magnus. The effectiveness of second high dose melphalan with autologous stem cell support in relapsed myeloma patients
10.40-10.50
Konstantinova Tatiana. Hematopoietic stem cell transplantation (HSCT) in the treatment of Hodgkin’s lymphoma (HL) patients: Experience in the Sverdlovsk region
Session 5. Hematopoietic Stem Cell Transplantation: Aplastic Anemia
Chairmen: J. Marsh, I. Muller, A. Rumyantsev
10.50-11.10
Kojima Seiji. Treatment of acquired aplastic anemia in children
11.10-11.30
Marsh Judith. Current aplastic anaemia guidelines and unresolved problems
11.30-11.40
Novichkova Galina. Treatment results of children with acquired aplastic anemia after failed first course of combining immunosuppressive therapy
11.40-11.50
Kulagin Alexander. Bone marrow transplantation and immunosuppressive therapy for acquired aplastic anemia: A 15-year two-center experience
11.50-12.10
Coffee break and posters
Session 6. Hematopoietic Stem Cell Transplantation: Infection complications
Chairmen: H. Lellek, A. Maschan, G. Maschmeyer
12.10-12.30
Maschmeyer Georg. Pre-emptive approach to invasive fungal infections therapy
12.30-12.50
Lellek Heinrich. Treatment of fungal diseases post BMT
12.50-13.10
Bialek Ralf. PCR-Diagnostic of fungal infections
13.10-13.25
Klimko Nicolay. International guidelines on IFI management (ECIL 3)
13.25-13.40
Klyasova Galina. Optimizing antimicrobial therapy: From the bench to the bedside
13.40-13.50
Vavilov Vladimir. Epidemiology and structure of septic complications in HSCT recipients
13.50-15.00
Lunch. Poster session
Session 7. Basic researches
Chairmen: G. Wagemaker, B. Fehse, M. Borset
15.00-15.20
Sanderson Ralph. Heparanase promotes the aggressive phenotype of myeloma tumors and is a novel target for myeloma therapy
15.20-15.40
Koza Vladimir. WMDP accreditation – mission (im)possible
15.40-16.00
Borset Magne. Multiple Myeloma - Interactions between tumor and microenvironment
16.00-16.20
Fehse Boris. LeGO vectors for colourful cell marking in cell biology studies
16.20-16.40
Poster Awards
Chairmen: V. Savchenko, F. Wisloff, A. Zander, G. Mentkevich
16.40-17.00
Closing Remarks
last updated 30 August 2010